JBS presents global protein diversification strategy in investor presentation
JBS•JBS's investor presentation showed adjusted EBITDA of $5.46 billion for the 12 months through the third quarter of 2026, alongside $515 million in free cash outflow and $2.58 billion in capital spending.
1. Financial figures
JBS reported adjusted EBITDA of $5.46 billion for the 12 months through the third quarter of 2026. Free cash outflow was $515 million, and capital spending totaled $2.58 billion.
2. Debt and leverage
Third-quarter net debt stood at $19.31 billion, with net leverage of 3.54 times EBITDA. Debt had an average maturity of 14.4 years and an average annual cost of 5.7%.
